Search

Your search keyword '"Townsend, David"' showing total 124 results

Search Constraints

Start Over You searched for: Author "Townsend, David" Remove constraint Author: "Townsend, David" Database MEDLINE Remove constraint Database: MEDLINE
124 results on '"Townsend, David"'

Search Results

1. A novel peptide-based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathies.

2. Characterization of Olive Oil Phenolic Extracts and Their Effects on the Aggregation of the Alzheimer's Amyloid-β Peptide and Tau.

3. Factors leading to diagnostic delay in tuberculosis in the tropical north of Australia.

4. Editorial: New ideas in language sciences: linguistics.

5. Unveiling the Mechanism of the in Situ Formation of 3D Fiber Macroassemblies with Controlled Properties.

6. Asgard archaea shed light on the evolutionary origins of the eukaryotic ubiquitin-ESCRT machinery.

7. A Request for Scientific Accountability in Public Statements.

8. A Rare Case of HHV-6 Encephalitis in an Immunocompetent Host: Case Report and Literature Review.

9. Impact behaviour of 3D printed cellular structures for mouthguard applications.

10. Identification of venular capillary remodelling: a possible link to the development of periodontitis?

11. 19 F Solid-State NMR and Vibrational Raman Characterization of Corticosteroid Drug-Lipid Membrane Interactions.

12. Patient-specific Extravasation Dosimetry Using Uptake Probe Measurements.

13. Validation of low-dose lung cancer PET-CT protocol and PET image improvement using machine learning.

14. COVID-19 and the importance of space in entrepreneurship research and policy.

17. Aggregation Kinetics and Filament Structure of a Tau Fragment Are Influenced by the Sulfation Pattern of the Cofactor Heparin.

18. Raman Spectroscopy with 2D Perturbation Correlation Moving Windows for the Characterization of Heparin-Amyloid Interactions.

19. Circular Dichroism Spectroscopy Identifies the β-Adrenoceptor Agonist Salbutamol As a Direct Inhibitor of Tau Filament Formation in Vitro .

20. Quality Improvement Initiatives to Assess and Improve PET/CT Injection Infiltration Rates at Multiple Centers.

21. Brown Adipose Tissue: Multimodality Evaluation by PET, MRI, Infrared Thermography, and Whole-Body Calorimetry (TACTICAL-II).

22. Pseudo-nitzschia bloom dynamics in the Gulf of Maine: 2012-2016.

23. Low dose positron emission tomography emulation from decimated high statistics: A clinical validation study.

24. Sub-clinical abnormalities detected by PET/MRI in household tuberculosis contacts.

25. Correlation Between Personal Health History and Depression Self-Care Practices and Depression Screening Among African Americans With Chronic Conditions.

26. Hybrid PET/CT and PET/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction.

27. Orientation of a Diagnostic Ligand Bound to Macroscopically Aligned Amyloid-β Fibrils Determined by Solid-State NMR.

28. Development of a Dedicated Rebinner with Rigid Motion Correction for the mMR PET/MR Scanner, and Validation in a Large Cohort of 11 C-PIB Scans.

29. Usefulness of Topically Applied Sensors to Assess the Quality of 18F-FDG Injections and Validation Against Dynamic Positron Emission Tomography (PET) Images.

30. Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin.

31. Predictors of confidence in anatomy knowledge for work as a junior doctor: a national survey of Australian medical students.

32. Frequency and nature of potentially harmful preventable problems in primary care from the patient's perspective with clinician review: a population-level survey in Great Britain.

33. Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study.

34. Stage Salience and Situational Likelihood in the Formation of Situation Models during Sentence Comprehension.

35. Development and piloting of a survey to estimate the frequency and nature of potentially harmful preventable problems in primary care from a UK patient's perspective.

36. Capsinoids activate brown adipose tissue (BAT) with increased energy expenditure associated with subthreshold 18-fluorine fluorodeoxyglucose uptake in BAT-positive humans confirmed by positron emission tomography scan.

37. Quantitative 18 F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring.

40. A comparison of 18F-FDG PET/MR with PET/CT in pulmonary tuberculosis.

41. Characterization of 176 Lu background in LSO-based PET scanners.

42. Heparin and Methionine Oxidation Promote the Formation of Apolipoprotein A-I Amyloid Comprising α-Helical and β-Sheet Structures.

44. Recombinant fowlpox virus vector-based vaccines: expression kinetics, dissemination and safety profile following intranasal delivery.

45. Quantitative Accuracy and Lesion Detectability of Low-Dose 18 F-FDG PET for Lung Cancer Screening.

46. History and future technical innovation in positron emission tomography.

47. Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.

49. A method to assess image quality for Low-dose PET: analysis of SNR, CNR, bias and image noise.

50. Vascular Fragility and the Endothelial Glycocalyx in the Tissues Lining the Healthy Gingival Crevice.

Catalog

Books, media, physical & digital resources